REQUEST A DEMO
Total
USD $0.00
Search more companies

Viro Med Co.,Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing | Research and Development in the Physical, Engineering, and Life Sciences
Full name: Viro Med Co.,Ltd. Profile Updated: July 23, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

ViroMed Co., Ltd. is a leading biotechnology company headquartered in Seoul, Korea. With a US presence in Atlanta, the company has established itself as one of the most scientifically advanced R&D companies in the global biopharmaceutical industry. ViroMed's mission is to discover and develop innovative biopharmaceuticals for human diseases. The company has a diverse pipeline of novel biologics and herbal therapeutics focused on cardiovascular disease, cancer, and immune disorders. They are currently conducting multiple clinical studies in the US, Korea, and China. ViroMed is publicly listed on KOSDAQ (084990). ViroMed Laboratories, a member of Labcorp's Specialty Testing Group, is an FDA-registered laboratory that provides infectious disease testing for human cells, tissues, and cellular and tissue-based products (HCT/Ps) donor clients. They perform donor testing at Labcorp's premier laboratory campus in Burlington, North Carolina. With over a decade of experience serving the tissue donor industry, ViroMed Laboratories has been awarded ISO15189 certification, ensuring the highest quality test offerings. The company prides itself on its quality improvement process and dedicated account management staff, which provides exceptional customer service.

Headquarters
21, Magok Central 8-Ro 7-Gil, Gangseo-Gu
Seoul; Seoul;

Contact Details: Purchase the Viro Med Co.,Ltd. report to view the information.

Website: http://www.viromed.co.kr

Basic Information
Total Employees:
Purchase the Viro Med Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Viro Med Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Viro Med Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Viro Med Co.,Ltd. report to view the information.
Incorporation Date:
November 21, 1996
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Auditor
Ownership Details
Purchase this report to view the information.
10.78%
Purchase this report to view the information.
2.89%
Purchase this report to view the information.
0.26%
Purchase this report to view the information.
0.17%
Purchase this report to view the information.
0.14%
Subsidiaries
Genopis Inc
Helixmith Usa Inc
㈜골든헬릭스
Company Performance
Financial values in the chart are available after Viro Med Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-40.17%
Total operating revenue
-36.35%
Operating profit (EBIT)
51.89%
EBITDA
41.41%
Net Profit (Loss) for the Period
50.18%
Total assets
-35.9%
Total equity
-28.57%
Operating Profit Margin (ROS)
176.33%
Net Profit Margin
126.95%
Return on Equity (ROE)
2.86%
Debt to Equity Ratio
-9.6%
Quick Ratio
10.05%
Cash Ratio
1.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?